article thumbnail

Cardiac Sonography: How AI and Other Innovations Are Changing Ultrasound

Cassling

At the same time, the growing prevalence of complex cardiovascular conditions means assessing more nuanced, multifaceted presentations of heart disease. Heres a look at how AI ultrasound and other tech innovations are helping cardiologists work faster while driving better outcomes for patients.

article thumbnail

How Echo IQ Transforms Heart Disease Diagnosis with Cutting-Edge AI

Cassling

What does the future of heart disease detection look like? He also discusses how this innovative solution is not just advancing diagnostic precision but also reshaping the way healthcare providers approach heart disease treatment and patient care.

article thumbnail

New Technology Promises to Revolutionize Valvular Heart Disease Care

DAIC

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?

article thumbnail

Cleerly Launches Cleerly ISCHEMIA Solution for Heart Disease Analysis

DAIC

milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heart disease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. We are proud to support healthcare professionals personalize patients' heart health journeys.

Ischemia 119
article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , This procedure was carried out at the Narayana Hrudayalaya Institute of Cardiac Sciences in Bengaluru, India, and represents a milestone in the treatment of heart disease using the SSi Mantra Surgical Robotic System. from 2022 to 2031.

article thumbnail

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

DAIC

milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

article thumbnail

A pulse of innovation: AI at the service of heart research

Science Daily - Heart Disease

Researchers unveiled BeatProfiler, a groundbreaking new tool -- a comprehensive software that automates the analysis of heart cell function from video data.

Research 121